Innoviva (INVA) EBIAT (2016 - 2025)
Innoviva (INVA) has disclosed EBIAT for 16 consecutive years, with $89.9 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, EBIAT rose 7312.04% year-over-year to $89.9 million, compared with a TTM value of $109.6 million through Sep 2025, up 752.96%, and an annual FY2025 reading of $271.2 million, up 1059.22% over the prior year.
- EBIAT was $89.9 million for Q3 2025 at Innoviva, up from $63.7 million in the prior quarter.
- Across five years, EBIAT topped out at $229.3 million in Q3 2022 and bottomed at -$46.6 million in Q1 2025.
- Average EBIAT over 5 years is $42.4 million, with a median of $34.9 million recorded in 2023.
- The sharpest move saw EBIAT crashed 2809.77% in 2024, then skyrocketed 7312.04% in 2025.
- Year by year, EBIAT stood at -$6.0 million in 2021, then tumbled by 70.56% to -$10.3 million in 2022, then tumbled by 92.43% to -$19.8 million in 2023, then soared by 113.1% to $2.6 million in 2024, then skyrocketed by 3358.0% to $89.9 million in 2025.
- Business Quant data shows EBIAT for INVA at $89.9 million in Q3 2025, $63.7 million in Q2 2025, and -$46.6 million in Q1 2025.